CTLA4 and breast carcinoma: Additionally, LRBA was shown to be involved in trafficking key immune checkpoints (e.g., CTLA-4), is known to contribute to immune dysregulation [32], and is correlated with both disease mortality and recurrence in breast cancer [7].